Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7786621 | 0.86 | RAB9A (0.40) | MAPTTHRBRAB9AMEN1KMT2A | |
| SCHEMBL13304546 | 0.85 | GAA (0.42) | MAPTTHRBRAB9ACYP1A2CYP3A4 | |
| SCHEMBL3109031 | 0.79 | RAB9A (0.36) | MAPTRAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL13304627 | 0.78 | HPGD (0.46) | MAPTRAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL4107508 | 0.77 | ALDH1A1 (0.38) | RAB9AALDH1A1HSD17B10NPC1 | |
| SCHEMBL12424053 | 0.76 | RAB9A (0.39) | MAPTTHRBRAB9ACYP1A2CYP3A4 | |
| SCHEMBL13478964 | 0.76 | RAB9A (0.37) | MAPTTHRBRAB9ACYP1A2CYP3A4 | |
| SCHEMBL12424046 | 0.74 | CHRM3 (0.44) | MAPTTHRBCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL6689669 | 0.73 | KMT2A (0.40) | MAPTTHRBCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL12424057 | 0.73 | CHRM3 (0.44) | MAPTTHRBRAB9ACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2192115-A1 | 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms | Bayer CropScience AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | MCRS1, MRM1, PADI1 | MAPT 3644/4885THRB 2963/4885RAB9A 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.